产后立即放置左炔诺孕酮宫内节育器与母乳喂养结局:一项非劣效性随机对照试验
在美国犹他大学和新墨西哥大学健康科学中心开展的产科非劣效性随机对照试验(2014年2月至2016年3月)显示,产后立即放置左炔诺孕酮宫内节育器(LNG-IUD)与延迟至产后4–12周放置相比,8周时母乳喂养持续率(79% vs 84%)和泌乳启动时间(65.3 vs 63.6小时)均达到非劣效。立即放置组的IUD脱落率显著更高(19% vs 2%,P<.001)。
要点
- 产后立即放置LNG-IUD在8周母乳喂养持续率上不劣于延迟放置(79% vs 84%,95%CI -5.6至15%)。
- 泌乳启动时间两组非劣效,立即组65.3±25.7小时 vs 延迟组63.6±21.6小时,平均差1.7小时(95%CI -4.8至8.2)。
- 立即放置组IUD脱落率显著高于延迟组(19% vs 2%,P<.001),两组均无子宫穿孔。
核心结论
- 产后立即与延迟放置LNG-IUD的母乳喂养结局为非劣效,表明立即放置是计划母乳喂养并使用LNG-IUD女性的可接受选择。
- 作者建议应向计划使用LNG-IUD的母乳喂养女性提供产后立即放置IUD的选项。
研究设计与样本
- 在犹他大学和新墨西哥大学健康科学中心进行的非劣效性随机对照试验,2014年2月至2016年3月招募。
- 纳入孕龄18–40岁、计划母乳喂养、希望使用LNG-IUD的孕妇,按1:1随机分为产后立即放置组或产后4–12周延迟放置组。
- 预设排除标准包括分娩孕龄<37.0周、绒毛膜羊膜炎、产后出血、LNG-IUD放置禁忌及可能影响母乳喂养的妊娠并发症。
- 主要分析采用符合方案分析(非劣效性研究的标准方法),同时报告意向性分析;主要结局为8周母乳喂养持续率,非劣效界值15%,每组需132例。
- 随访6个月;仅数据分析团队对干预分配设盲。
主要发现
- 最终分析样本为立即组132例和延迟组127例;立即组8周时母乳喂养报告率为79%(95%CI 70–86%),延迟组为84%(95%CI 76–91%),组间差异5%落在非劣效界值内(95%CI -5.6至15%)。
- 泌乳启动时间(均值±标准差)立即组为65.3±25.7小时,延迟组为63.6±21.6小时,平均差异1.7小时(95%CI -4.8至8.2小时),对数秩检验非劣效。
- 立即组发生24例IUD脱落,延迟组2例(19% vs 2%,P<.001);两组均无IUD穿孔。
关键数值与推荐
- 非劣效性主要结局:8周母乳喂养持续率立即组79%(95%CI 70–86%)vs 延迟组84%(95%CI 76–91%),差异5%(95%CI -5.6至15%)。
- 泌乳启动时间立即组65.3±25.7小时 vs 延迟组63.6±21.6小时,平均差1.7小时(95%CI -4.8至8.2小时)。
- IUD脱落立即组24例(19%)vs 延迟组2例(2%),P<.001。
临床怎么用
- 作者建议应向计划使用LNG-IUD的母乳喂养女性提供产后立即放置IUD的选项。
- 作者认为立即放置的脱落率较高,但这一劣势可能被立即启动避孕的优势所抵消。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Immediate postpartum levonorgestrel intrauterine device insertion is increasing in frequency in the United States, but few studies have investigated the effect of early placement on breast-feeding outcomes. OBJECTIVE: This study examined the effect of immediate vs delayed postpartum levonorgestrel intrauterine device insertion on breast-feeding outcomes. STUDY DESIGN: We conducted this noninferiority randomized controlled trial at the University of Utah and the University of New Mexico Health Sciences Centers from February 2014 through March 2016. Eligible women were pregnant and planned to breast-feed, spoke English or Spanish, were aged 18-40 years, and desired a levonorgestrel intrauterine device. Enrolled women were randomized 1:1 to immediate postpartum insertion or delayed insertion at 4-12 weeks' postpartum. Prespecified exclusion criteria included delivery <37.0 weeks' gestational age, chorioamnionitis, postpartum hemorrhage, contraindications to levonorgestrel intrauterine device insertion, and medical complications of pregnancy that could affect breast-feeding. We conducted per-protocol analysis as the primary approach, as it is considered the standard for noninferiority studies; we also report the alternative intent-to-treat analysis. We powered the study for the primary outcome, breast-feeding continuation at 8 weeks, to detect a 15% noninferiority margin between groups, requiring 132 participants in each arm. The secondary study outcome, time to lactogenesis, used a validated measure, and was analyzed by survival analysis and log rank test. We followed up participants for ongoing data collection for 6 months. Only the data analysis team was blinded to the intervention. RESULTS: We met the enrollment target with 319 participants, but lost 34 prior to randomization and excluded an additional 26 for medical complications prior to delivery. The final analytic sample included 132 in the immediate group and 127 in the delayed group. Report of any breast-feeding at 8 weeks in the immediate group (79%; 95% confidence interval, 70-86%) was noninferior to that of the delayed group (84%; 95% confidence interval, 76-91%). The 5% difference in breast-feeding continuation at 8 weeks between the groups fell within the noninferiority margin (95% confidence interval, -5.6 to 15%). Time to lactogenesis (mean ± SD) in the immediate group, 65.3 ± 25.7 hours, was noninferior to that of the delayed group, 63.6 ± 21.6 hours. The mean difference between groups was 1.7 hours (95% confidence interval, -4.8 to 8.2 hours), noninferior by log-rank test. A total of 24 intrauterine device expulsions occurred in the immediate group compared to 2 in the delayed group (19% vs 2%, P < .001), consistent with the known higher expulsion rate with immediate vs delayed postpartum intrauterine device insertion. No intrauterine device perforations occurred in either group. CONCLUSION: Our results of noninferior breast-feeding outcomes between women with immediate and delayed postpartum levonorgestrel intrauterine device insertion suggest that immediate postpartum intrauterine device insertion is an acceptable option for women planning to breast-feed and use the levonorgestrel intrauterine device. Expulsion rates are higher with immediate postpartum levonorgestrel intrauterine device insertion compared to delayed insertion, but this disadvantage may be outweighed by the advantages of immediate initiation of contraception. Providers should offer immediate postpartum intrauterine device insertion to breast-feeding women planning to use the levonorgestrel intrauterine device.
引用
- Turok DK, Leeman L, Sanders JN, et al. Immediate postpartum levonorgestrel intrauterine device insertion and breast-feeding outcomes: a noninferiority randomized controlled trial. Am J Obstet Gynecol. 2017. PMID: 28842126. doi:10.1016/j.ajog.2017.08.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。